AI tech generates early details and analysis
on newsworthy events
NEW
YORK, May 2, 2024 /PRNewswire/ -- Today,
AppliedXL announced a new collaboration with Bloomberg to deliver
all Bloomberg Terminal users with key insights to help them get
ahead of catalyst events in the pharmaceutical industry.
AppliedXL's AI technology analyzes live public data to uncover
signals and niche trends, distilling it into early news stories
that Bloomberg will include in real-time news feeds used for early
signal detection and market analysis.
The first real-time news vertical that AppliedXL will make
available on the Bloomberg Terminal covers the life sciences and
biopharma space, encompassing public and private biotech and
pharmaceutical companies. Bloomberg Terminal users will be alerted
to irregularities in clinical trial progressions and other events
that may move the market. In tandem, they'll get real-time analysis
of how those occurrences impact the individual company as well as
related companies and markets, creating a more efficient
workflow.
AppliedXL's artificial intelligence (AI) traces digital
breadcrumbs and recognizes patterns from past events to create
templates, apply them to what's happening in real-time, and predict
likely outcomes. Because these information blueprints vary from one
coverage area to another, AppliedXL's algorithms are meticulously
tailored for specific verticals. They're developed and audited in
collaboration with journalists who use their domain expertise to
review data, help develop interpretations, and validate the quality
of the output during the AI training process. Further, the AI
technology runs an automatic fact-checking process to help decipher
accurate information.
"There's no artificial intelligence without human wisdom. We use
machines to understand the patterns in data but we need humans to
understand the contexts that influence them," said Francesco Marconi, Co-Founder & CEO of
AppliedXL. "We're excited to empower Bloomberg Terminal users with
AppliedXL's well-formulated, real-time news briefings that help
them get ahead of the curve."
AppliedXL focuses on surfacing and distilling the highest
quality of information rather than presenting users with an
overwhelmingly comprehensive download. This saves precious time for
investors looking to stay ahead of market-moving events and
decision makers at companies working to lead proactively.
AppliedXL's real-time news briefings for biopharma assess over
7,000 daily updates to clinical trials and generate 60-80 stories
covering the most noteworthy events every day. From the vast reams
of data emitted by nearly 100 categories of both domestic and
international industry-sponsored interventional clinical trials,
AppliedXL identifies the news signals that are likely to indicate
catalyst events. The human-tailored, machine-learning models output
precise, contextualized information and analysis that enables
journalists to develop news quickly, investors to act early, and
decision makers at companies to lead proactively.
To learn more about how your organization could benefit from
AppliedXL's real-time news briefings, visit
https://www.appliedxl.com/.
About AppliedXL
AppliedXL is an AI and Computational
Journalism company based in New York
City. Its AI network gathers and analyzes data in real-time,
delivering actionable briefings of likely outcomes based on past
predictions. AppliedXL is trained to look at the data it collects
with the eyes of investigative journalists, automatically
fact-checking as well as applying editorial standards. It sifts
through trusted sources of data and distills what's most important
for decision makers. To learn more about AppliedXL's API, visit
https://www.appliedxl.com/.
Press Contact
Frank
Spence
377035@email4pr.com
(415) 294-1157
View original content to download
multimedia:https://www.prnewswire.com/news-releases/appliedxl-collaborates-with-bloomberg-to-provide-ai-powered-real-time-pharma-news-on-the-bloomberg-terminal-302134574.html
SOURCE AppliedXL